Pharmaceutical patents | Intellepedia

Abbott’s HIV Drug Patent “Not an Invention”

The Indian Patent Office has rejected Abbott’s application for an HIV drug patent, finding no inventive step in the claimed composition. This decision highlights the robust scrutiny applied to pharmaceutical patents in India and the importance of pre grant opposition in safeguarding public health interests.

Once an Intermediate, Always an Intermediate

This post examines the exclusion of patentability for new uses of known intermediates under Section 3d of the Indian Patents Act. It discusses the statutory language, its implications for pharmaceutical innovation, and whether this aligns with the broader objectives of the patent system in India.

Something More About Swiss Type Claims

This post explores the rationale, development and eventual redundancy of Swiss type claims in patent law. It analyses legal changes in Europe and India regarding second medical use, absolute novelty and recent judicial clarifications.

Temporary Injunction – F. Hoffmann-LA Roche Vs. Cipla

The Court refused a temporary injunction in the Roche vs Cipla patent dispute, highlighting non-disclosure, validity challenges, and public interest considerations. This analysis discusses the legal principles applied and the balance between patent rights and access to essential medicines.

Aktiengesellschaft Vormals Meister Lucius & Bruning a Corporation etc.Vs Unichem Laboratories

This post provides a detailed analysis of the Tolbutamide patent infringement case between Aktiengesellschaft Vormals Meister Lucius & Bruning and Unichem Laboratories. It discusses the Court’s interpretation of patent claims and the implications for Indian pharmaceutical patent litigation.

Collar patents for snakes, Foldable iPhone Patent, SIPP Stakeholders meeting, USPTO hikes fees, MSF v. Pfizer, Pneumonia vaccine patent, Roche V Pfizer, Microsoft patent infringement, Patent opposition in India, Patent Tip of the Week and other Weekly Patent News

This week’s patent news highlights notable patent filings, litigations, and policy updates in India. Key stories include MSF’s challenge to Pfizer’s pneumonia vaccine patent, Apple’s foldable iPhone application, and USPTO’s fee hike. The post also reviews patent opposition mechanisms and recent Indian Patent Office statistics.

Military patents, Iron man suit, Glove patents, Unique seminar on patents, MSF vs Pfizer, Dr. Reddy’s patents, Nintendo vs. iLife, Hytera vs. Motorola, Innovation patents, Portfolio Pruning, Patent Tip of the Week and more.

This update covers major Indian and international patent news, including litigation, innovation, and key statistics. Highlights include the Iron Man suit invention, glove patents, pharmaceutical litigation, and patent seminars. The post also offers practical guidance on patent portfolio management.

Delhi High Court, Upcoming events, Xiaomi patents and more.

This update examines patent infringement rulings by the Delhi High Court, statistics from the Indian Patent Office, international patent acquisitions, and licensing settlements. It also features expert analysis and practical guidance for patent applicants.

Apple sues Qualcomm again, Major Setback to Bayer, Delhi HC allows export of patented drug and much more.

This update highlights key events in intellectual property law, including Apple’s lawsuit against Qualcomm and Bayer’s loss in the Delhi High Court. Further, it discusses recent trademark and patent disputes as well as upcoming conferences, offering an objective legal perspective.

UNDP Issues Guidelines For Pharmaceutical Patent Examination

The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of TRIPS flexibilities to curb evergreening and improve access to medicines.